atropine: be given before irinotecan

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.66
, alkaloid
Weight: 0.59
, agent
Weight: 0.57
, substance
Weight: 0.55
, medicine
Weight: 0.51
Siblings phenobarbital
Weight: 0.36
, acetaminophen
Weight: 0.36
, ibuprofen
Weight: 0.35
, morphine
Weight: 0.35
, metronidazole
Weight: 0.35

Related properties

Property Similarity
be given before irinotecan 1.00
be given with irinotecan 0.99
be given with neostigmine 0.79
be administered with neostigmine 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.24
Rule weight: 0.28
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.84
Plausible(atropine, be given before irinotecan)
Evidence: 0.87
¬ Salient(atropine, be given before irinotecan)

Similarity expansion

0.80
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.99
Evidence: 0.90
Typical(atropine, be given before irinotecan)
Evidence: 0.50
¬ Typical(atropine, be given with irinotecan)
0.77
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.99
Evidence: 0.87
Salient(atropine, be given before irinotecan)
Evidence: 0.70
¬ Salient(atropine, be given with irinotecan)
0.72
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.99
Evidence: 0.84
Plausible(atropine, be given before irinotecan)
Evidence: 0.92
¬ Plausible(atropine, be given with irinotecan)
0.64
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.79
Evidence: 0.90
Typical(atropine, be given before irinotecan)
Evidence: 0.58
¬ Typical(atropine, be given with neostigmine)
0.62
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.79
Evidence: 0.87
Salient(atropine, be given before irinotecan)
Evidence: 0.68
¬ Salient(atropine, be given with neostigmine)
0.62
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.79
Evidence: 0.84
Plausible(atropine, be given before irinotecan)
Evidence: 0.58
¬ Plausible(atropine, be given with neostigmine)
0.62
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.75
Evidence: 0.90
Typical(atropine, be given before irinotecan)
Evidence: 0.42
¬ Typical(atropine, be administered with neostigmine)
0.60
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.75
Evidence: 0.87
Salient(atropine, be given before irinotecan)
Evidence: 0.51
¬ Salient(atropine, be administered with neostigmine)
0.60
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.75
Evidence: 0.84
Plausible(atropine, be given before irinotecan)
Evidence: 0.44
¬ Plausible(atropine, be administered with neostigmine)
0.57
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.99
Evidence: 0.52
Remarkable(atropine, be given before irinotecan)
Evidence: 0.68
¬ Remarkable(atropine, be given with irinotecan)
0.46
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.79
Evidence: 0.52
Remarkable(atropine, be given before irinotecan)
Evidence: 0.69
¬ Remarkable(atropine, be given with neostigmine)
0.44
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.75
Evidence: 0.52
Remarkable(atropine, be given before irinotecan)
Evidence: 0.67
¬ Remarkable(atropine, be administered with neostigmine)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.87
Salient(atropine, be given before irinotecan)
Evidence: 0.90
¬ Typical(atropine, be given before irinotecan)
Evidence: 0.52
¬ Remarkable(atropine, be given before irinotecan)

Typical implies Plausible

0.41
Rule weight: 0.48
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.84
Plausible(atropine, be given before irinotecan)
Evidence: 0.90
¬ Typical(atropine, be given before irinotecan)